Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$756K Sell
5,883
-45
-0.8% -$5.27K 0.6% 45
2026
Q1
$713K Buy
5,928
+53
+0.9% +$6.12K 0.64% 44
2025
Q4
$618K Sell
5,875
-298
-5% -$28K 0.55% 47
2025
Q3
$518K Sell
6,173
-142
-2% -$11.7K 0.48% 50
2025
Q2
$500K Sell
6,315
-2,672
-30% -$212K 0.49% 49
2025
Q1
$829K Sell
8,987
-486
-5% -$45.4K 0.81% 37
2024
Q4
$963K Buy
+9,473
New +$977K 0.93% 34

Other funds holding MRK

Roxbury Financial's MRK Position: Q2 2026 in Review

Roxbury Financial reduced its Merck (MRK) stake by 0.76% in Q2 2026, selling an estimated $5.27K and leaving 5,883 shares worth $756K. The position accounts for 0.6% of the portfolio, ranked #45.

Roxbury Financial first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $963K in Q4 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Roxbury Financial held 5,883 shares of Merck worth $756K as of Q2 2026.
  • Roxbury Financial sold 45 Merck shares in Q2 2026, an estimated $5.27K.
  • Merck made up 0.6% of Roxbury Financial's portfolio in Q2 2026, its #45 holding.
  • Roxbury Financial first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Roxbury Financial's Merck position peaked at $963K in Q4 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.